CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,248 | -30.5% | 12,400 | -12.7% | 0.00% | -100.0% |
| Q2 2023 | $491,036 | +156780.5% | 14,200 | +61.4% | 0.00% | – |
| Q1 2023 | $313 | -36.8% | 8,800 | -20.7% | 0.00% | – |
| Q4 2022 | $495 | -100.0% | 11,100 | -77.4% | 0.00% | -100.0% |
| Q2 2022 | $1,369,000 | +51.6% | 49,200 | +88.5% | 0.00% | +100.0% |
| Q1 2022 | $903,000 | -4.1% | 26,100 | +7.9% | 0.00% | -50.0% |
| Q4 2021 | $942,000 | +44.0% | 24,200 | +92.1% | 0.00% | – |
| Q3 2021 | $654,000 | +87.4% | 12,600 | -45.2% | 0.00% | -100.0% |
| Q3 2020 | $349,000 | +26.0% | 23,000 | +3.6% | 0.00% | – |
| Q2 2020 | $277,000 | +1219.0% | 22,200 | +86.6% | 0.00% | – |
| Q1 2020 | $21,000 | -55.3% | 11,900 | -44.7% | 0.00% | – |
| Q3 2019 | $47,000 | -56.5% | 21,500 | -46.6% | 0.00% | – |
| Q2 2019 | $108,000 | -50.9% | 40,252 | -10.0% | 0.00% | – |
| Q1 2019 | $220,000 | – | 44,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|